IL6 and COVID-19: The dexamethasone therapy itself may not influence IL-6 level, which is supported by an analysis of the transcriptomic data that indicates the therapeutic mechanism of dexamethasone in severe COVID-19 patients does not involve IL-6 pathway [6].